In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Enterome gets €10mm so far in Series B

Executive Summary

Enterome Bioscience SA (creating drugs and diagnostics for microbiome-related diseases) raised €10mm ($13.8mm) in the first tranche of its Series B financing to returning shareholders Seventure, Lundbeckfond Ventures, and Omnes Capital. Funds will support continued development of its Metagenotyping process used in biomarker discovery and patient stratification in conditions such as metabolic and inflammatory bowel diseases.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies